← All Sponsors
SPONSOR

Institute of Hematology and Blood Transfusion, Czech Republic

Total Trials
1
Recruiting
1
Phases
EARLY_Phase 1
Conditions studied: Leukemia, Myeloid, Acute(AML)Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes (MDS)Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
NCT06765876 EARLY_Phase 1
Recruiting

CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial

Leukemia, Myeloid, Acute(AML)
Czechia View Trial →